Monash AI model may help epilepsy patients become seizure-free

The 2D plane shows the machine learning model is able to

identify patterns between patients at the different centres.

A study led by Monash University and believed to be a world first has demonstrated that an Artificial Intelligence (AI)  model can potentially predict the best personalised, anti-seizure medication for patients with newly diagnosed epilepsy.

The predictive model, once fully developed, would spare these patients the uncertainty of not knowing when their lives would be returned to normal by taking anti-seizure medications, and possibly the harmful side-effects associated with some drugs.

See faculty story here.

Sonika Tyagi finalist in Women in AI 2022 awards

Dr Sonika Tyagi

Dr Sonika Tyagi has been selected as one of three finalists for the Women in AI [Artificial Intelligence] awards for 2022, in the category of AI in Health (see finalist list).

Dr Tyagi is currently a Machine Learning lead in the SuperbugAI flagship project, which brings together researchers and clinicians from the Monash Faculty of Medicine, Nursing and Health Sciences, Central Clinical School, Faculty of IT and Monash Data Futures Institute. Her expertise is in developing new machine learning tools and pipelines, and applying these methods to solve biological research questions.